Digital Health Research

Digital Health in Oncology (Executive Briefing)

Report access and advisory support are available through Galen Growth.

Digital Health Ecosystem for Oncology (Executive Briefing)

This is the Executive Briefing of the Digital Health in Oncology (Premium) report which is exclusively available to HealthTech Alpha Pro and HealthTech Alpha Enterprise users.

HealthTech Alpha, a Galen Growth proprietary solution, powers this report!

Key Insights

  • Oncology ventures dominated digital health landscape, raised significant funding, formed partnerships over 5 years.
  • Funding for Oncology ventures in Q1 2023 decreased by 88% YoY. Neurology took top spot.
  • Partnership activity remains strong, especially in Medical Diagnostics cluster.
  • Regulatory filings for Oncology ventures stable from 2021 to 2022, indicating healthy ecosystem. Many secured funding in past 18 months and well-positioned to weather potential VC drought this year.

About our Premium Reports

Our Premium Reports are specialized reports that are only available to active users with HealthTech Alpha Pro and HealthTech Alpha Enterprise accounts and are provided at no additional cost.

About our Premium Reports

Our Premium Reports are specialized reports that are only available to active users with HealthTech Alpha Pro and HealthTech Alpha Enterprise accounts and are provided at no additional cost.

Source of Data

Galen Growth’s proprietary platform, HealthTech Alpha, provides the data source for this report. Corporate Business Development, Business Intelligence, and Digital Health Partnership teams worldwide prefer HealthTech Alpha, the world’s most-trusted Digital Health data, intel, and insights platform. Visit https://www.healthtechalpha.com to learn more about our data or https://www.galengrowth.com research for our reports.

Our Mission

Founded in 2016 by Digital Health experts, Galen Growth empowers global Fortune 500 companies, institutional investors, and promising Digital Health ventures to fast track their digital health strategy to create significant financial and social values. To find out more, visit https://www.galengrowth.com

Full access

Need full access to this research?

Contact Galen Growth to discuss full report access, advisory support, and HealthTech Alpha intelligence for your team. We will help you identify the right level of research access for your organization.

  • Full report access and downloadable research
  • HealthTech Alpha digital health intelligence
  • Advisory support for market, funding, and ecosystem analysis
Contact us for full access

Research context

Digital Health in Oncology (Executive Briefing) for digital health decision-makers

This research supports healthtech, digital health, investment, and healthcare innovation teams with structured market intelligence from Galen Growth and HealthTech Alpha.

Overview

Category

Stage

Total Funding

GGA Score

powered by